Search Results for "Pava Spasticity"
Original Source: Cardiac Disease and the Electrocardiogram in SCI Patients
The purpose of this three-year study is to determine the prevalence and incidence of the different types of cardiac disease and ECG abnormalities in SCI patients. Study goals are: (i) delineation of the specific types of heart disease that occur in the SCI population as manifested both pre-clinically and clinically and (ii) demonstration of their association with ECG findings. This will enable validation of scores and algorithms using the inexpensive and widely available ECG f...
Matching Channels
Matching News
New Spasticity Guideline Promotes Early Access To Physiotherapy, UK
According to a new guideline by the UK's National Institute for Health and Clinical Excellence (NICE), aiming to improve the mobility and comfort of young people below the age of 19 with spasticity, s...
WASHINGTON (MedPage Today) -- The FDA has approved an implantable infusion pump and catheter system for delivery of baclofen in the treatment of severe spasticity.
BRIEF-GW Pharma Sativex study shows MS spasticity benefits
LONDON, Oct 12 (Reuters) - GW Pharmaceuticals PLC : * Positive German sativex data presented at ectrims * confirms clinically relevant benefits in Multiple Sclerosis Spasticity
Cannabinoids for Treating Spasticity in Multiple Sclerosis
A preponderance of patients with MS suffer from spasticity, which can greatly impact quality of life. Can cannabinoids bring symptomatic relief where other therapies have failed? Therapeutic Advance...
Covidien completes $100M CNS Therapeutics deal
Drug and medical device maker Covidien PLC said Tuesday it completed its $100 million purchase of CNS Therapeutics.CNS makes gablofen, a generic version of a drug that treats severe spasticity, and i...
Almirall pays GW Pharma milestone on Sativex; reports 1st-qtr results
UK-based GW Pharmaceuticals (AIM: GWP) says that it has received commercialization approval for its cannabinoid-based prescription medicine Sativex from the authorities in Italy for the treatment of m...
XenoPort drops MS spasticity drug after PhIII flop
XenoPort has dropped multiple sclerosis spasticity candidate arbaclofen placarbil (AP) after a pivotal Phase III trial failed to meet its efficacy endpoints. Santa Clara, California-based XenoPort h...
Covidien to buy CNS Therapeutics for $100 million
Drug and medical device maker Covidien PLC said Monday it agreed to buy CNS Therapeutics, a company that makes treatments for pain and spasticity, for $100 million.CNS Therapeutics has one approved d...
Matching PubMed Articles
The privileged burial of the Pava Pieve (Siena, 8th Century AD).
The 6(th) archaeological excavation campaign performed at the 'Pieve di Pava' (San Giovanni d'Asso, Siena, Italy) unearthed a privileged stone burial of a single individual (US 2378), covered by a mon...
Characteristics of associated reactions in people with hemiplegic cerebral palsy.
Purposes. To investigate the relationship between associated reactions and a) spasticity, b) contracture and c) coordination. Methods. Associated reactions were measured as magnitude of muscle activit...
Importance and treatment of spasticity in multiple sclerosis : Results of the MOVE 1 study.
BACKGROUND: The impact of spasticity induced by multiple sclerosis (MS) on patients and the applied treatment options have so far been insufficiently studied. METHODS: This was a multicentre, retrospe...
Multiple sclerosis (MS)-related spasticity is associated with disability and impairment in quality of life. We report on a patient with secondary progressive MS and spastic tetraparesis (Expanded Disa...
The meaning of spasticity to people with multiple sclerosis: What can health professionals learn?
Purpose: Multiple sclerosis (MS) is the most common disabling neurological condition affecting young adults. One third of people on an American registry of people with MS (PWMS) reported having activi...
